Revance Therapeutics Inc

Revance Therapeutics Inc is a security (CUSIP 761330109) tracked across SEC portfolio filings. 1 registered fund positions totaling $1.9M via N-PORT as of 2021-02-28.

Summary

• Issuer: Revance Therapeutics Inc
• CUSIP: 761330109
• Asset category: EC
• 13F holders: 0
• N-PORT fund positions: 1
• N-PORT value: $1.9M
• N-PORT report: 2021-02-28

Top fund holders (N-PORT)

More

• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search